Free Account Opening + AMC Free Demat
Loading...
June 14, 2010 - June 17, 2010

Parabolic Drugs IPO Review & Recommendations

and recommend to "Avoid" the IPO.

Parabolic Drugs IPO Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 2 0
% 0.00 0.00 0.00 100.00 0.00

Parabolic Drugs IPO Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Avoid
Avoid

Parabolic Drugs IPO Capital Market Rating

The Captial Market (CapitalMarket.com) rating for Parabolic Drugs IPO is 35. Their analysis recommends Do not subscribe for the IPO.

Reviewer Rating Score Rating
Capital Market 35 Do not subscribe

Post Recommendation Manage Recommendations

Note:

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.